Contact Us |
The CIBMTR produces a highly detailed report on Survival Statistics that describes the use and outcome of autologous and allogeneic hematopoietic cell (HCT) transplantation in more than 500 centers that have participated in the CIBMTR. Since 2007, we estimate the CIBMTR collects data on nearly all allogeneic transplants performed in the US and 80% of autologous transplants. Prior to 2007, we estimate the CIBMTR captured 90% of all unrelated donor allogeneic transplants performed, 60-90% of related donor allogeneic transplants, and 65-75% of autologous transplants in the US.
For a preview of the information included in this report, see the List of Tables (PDF).
This report is available upon request to physicians for making treatment decisions and clinical investigators for planning clinical studies. Corporations can obtain a copy of this report as one of the many benefits we offer through our CIBMTR Corporate Membership Program.
To view PDF documents you will need Adobe Reader.